Not logged in? You're viewing the Free tier. Join for free or log in to access your membership content.
Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.
Disclosure: The author does not hold a position in BWXT.
← Back to Free Index

BWXT

Analysis as of: 2026-04-21
BWX Technologies, Inc.
BWXT designs, manufactures and services nuclear components, fuel and related systems for U.S. government, commercial nuclear and nuclear medicine customers.
aerospace defense energy healthcare nuclear
Jump to: SummaryAnalysisOpportunityRiskTrendsLE StructureThird Party Analyst Consensus

Summary

Scarce Nuclear Capacity, Modest Equity Torque
A rare defense-and-commercial nuclear manufacturer should keep compounding as backlog, fuel and services expand. But the stock already discounts much of the scarcity, so upside depends on clean conversion and cash evidence more than on a broader nuclear narrative.

Analysis

Thesis
BWXT should keep compounding as a scarce, licensed nuclear manufacturing and defense-fuel bottleneck: backlog conversion, commercial capacity expansion and adjacent fuel opportunities can lift revenue meaningfully by 2031, but the stock already reflects much of that scarcity so execution and cash conversion matter more than narrative alone.
Last Economy Alignment
BWXT benefits as AI-era power scarcity and defense modernization raise the value of its licensed nuclear sites, sole-source naval fuel role and qualified manufacturing capacity. Its capture surface is physical, regulated and hard to automate away, so it gains from looser cognition without suffering material software-style commoditization.
Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple
1.6x (from 5 most recent analyses)
Reasoning
BWXT owns real choke points in a tightening nuclear supply chain, so revenue should outgrow most industrial peers as naval work, special materials, commercial services and medical programs scale. But this is already a premium-rated strategic asset. I expect steady shareholder compounding, not another dramatic rerating, because the next leg up requires visible backlog conversion, clean integration and proof that adjacent fuel options become cash earnings.
Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary
BWXT’s main risk is conversion, not relevance. The franchise is protected by regulated assets and trust, but appropriations, NRC timing, plant throughput and acquisition integration determine how quickly demand turns into shipped revenue and cash. With the stock already carrying a scarcity premium, valuation risk is higher than business-model risk.
Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Last Economy Structure

AI Industrial Score
0.84
They own licensed nuclear factories and the sole U.S. Navy fuel position, so more demand for reliable power and defense capacity makes their bottlenecks more valuable. The risk is not that AI replaces them; it is that regulators, budgets and plant throughput slow how fast that scarcity turns into revenue.
Upgrade to Reader to also access: Score Decomposition, Confidence Level
Upgrade to Allocator to also access: Obsolescence Vectors, Pricing Fragility
Upgrade to Reader to also access: Constraint Benefit Score, Obsolescence Risk Score

Third Party Analyst Consensus

12-Month Price Target
$209.70
Upgrade to Reader to also access: Bull Case, Base Case, Bear Case